August 13th 2025, 3:00pm
By Ryan Scott
Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.
August 13th 2025, 1:00pm
By Aaron Gerds, MD, MS
Dr. Aaron Gerds explained when treatment with rusfertide will become accessible for patients with a myeloproliferative neoplasm like polycythemia vera.
August 12th 2025, 9:00pm
By Brian Sluga
I’m a testicular cancer survivor diagnosed at 20. My story is about finding strength, building routines, and sharing hope for those facing cancer.
August 12th 2025, 8:00pm
By Hideko Warner
A nurse with metastatic breast cancer praised biology-guided radiation for her slow-growing squamous cell cancer and the team's thoughtful care.
August 12th 2025, 7:00pm
By Alex Biese
Long-term follow-up data from the phase 3 MANIFEST 2 clinical trial have been revealed.
August 12th 2025, 5:03pm
Childhood cancer treatments can accelerate biological aging which increases survivors’ risk for long-term health issues like heart disease and obesity.
August 12th 2025, 4:00pm
By Tamron Little
I was facing rare mesothelioma alone at 21 years old, but sharing my story connected me to a community that offers hope and strength to keep fighting.
August 12th 2025, 3:00pm
By Spencer Feldman
The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, review date.
August 12th 2025, 1:00pm
By Bob Lane
A diverticulitis concern led to a prostate cancer diagnosis that shifted a patient's mindset and highlighted the importance of hisloved ones.
August 12th 2025, 12:10pm
By Amrita Krishnan, MD
Panelists emphasize the importance of multidisciplinary collaboration, patient education, and advocacy in managing multiple myeloma, while expressing optimism about emerging therapies like CAR T cells that offer deeper remissions and improved quality of life.
August 12th 2025, 12:05pm
Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T cell engagers, along with potent new CELMoD drugs, all offering more targeted and effective options for patients.
August 12th 2025, 12:00pm
Panelists discuss City of Hope’s collaborative partnership with community physicians, emphasizing expert evaluation at specialized centers while enabling ongoing treatment closer to home for convenience, coordinating common therapies like Daratumumab locally, reserving complex procedures such as stem cell transplants and clinical trials for specialized centers, and aiming to balance high-quality care with patient accessibility through integrated, personalized, and coordinated management across care settings.
August 11th 2025, 9:00pm
By Linda Cohen
Writing and reading help me stay grounded and find meaning while living with chronic cancer, balancing health, family and speaking out against hatred.
August 11th 2025, 8:00pm
By Dr. Ioana Bonta
In an interview with CURE, medical oncologist Dr. Ioana Bonta explains why lung cancer is not just a ‘smoker’s disease.’
August 11th 2025, 7:00pm
It is vital that clinical trials for patients with cancer shift to a more representative approach to accurately reflect real-world patient populations.
Basal Cell Carcinoma Basics, From Diagnosis to Treatment
Stage 2 Cervical Cancer: Key Facts and Updates for Patients
HR+/HER2– Breast Cancer: Diagnosis and Treatment Guide
So You Want To Be A Cancer Advocate